Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bionicjoeon Jun 22, 2019 12:00pm
63 Views
Post# 29852528

RE:RE:RE:RE:So Much Speculation

RE:RE:RE:RE:So Much Speculation
Longholder99 wrote: They could issue the NR the night before. Then discuss at the AGM. As long as the AGM attendees dont get unfair advantage anything can happen. Bashing running amock.....seemingly by one, maybe two posters posing as many. Must be something big coming for this concerted effort to be upon us. Good thing the market pays minimal to no attention to these ramblings. Acts and reacts based on information and of course the science.....not the supposition of some keyboard warrior. FyI I appreciate any and all good info I get here. I have neither the time or the resources to get the insight I have gotten from a select few posters on this board. Macer, Claridge, Eoganacht just to name a few and I apologize to some of you I missed. I use the ignore function liberally to weed out bashers and nut cases. Try it......it works.


Boy, you don't get around much do you?

If you want to see real bashing then visit the cannabis boards. What you see on this board is nothing.

Let me just mention that normally AGMs are not used by companies to release material news. By law a publically traded company must once a year allow a shareholder meeting at which time the main business is to vote directors in or out of office and to put to a vote any special proposal put forth. Traders have been inching up the sp gambling there will be a major company announcement just before the AGM. No surprise since it happens every year. Usually they sell after the AGM when they see it was a pretty much vanilla meeting.

Hope Dr. Kulkarni gives a recorded presentation. It would be helpful to get his latest views on the science now that the phase 1b trial is complete. Maybe he could shed some light on the condition of the 6 patients. His opinions could sway some fence sitters to at least have a better look at the stock.
Bullboard Posts